Approval · Notice of Compliance 12872 · 2011
FRAGMIN: Notice of Compliance 12872
Issued December 15, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12872
- Date
- December 15, 2011
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New Presentation
- Therapeutic class
- Anticoagulant, Antithrombotic Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FRAGMIN | 02377454 | Cancelled Post Market |
Medicinal ingredients
- DALTEPARIN SODIUM 2,500 UNIT per ML